Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Hypoglycemia in diabetes: The dark side of diabetes treatment. A patient-centered review.

Johnson-Rabbett B, Seaquist ER.

J Diabetes. 2019 Sep;11(9):711-718. doi: 10.1111/1753-0407.12933. Epub 2019 May 27. Review.

PMID:
30983138
2.

Duration and onset of action of high dose U-500 regular insulin in severely insulin resistant subjects with type 2 diabetes.

Shrestha RT, Kumar AF, Taddese A, Khowaja AA, Moheet A, Olawsky E, Eberly LE, Seaquist ER.

Endocrinol Diabetes Metab. 2018 Sep 10;1(4):e00041. doi: 10.1002/edm2.41. eCollection 2018 Oct.

3.

Central Mechanisms of Glucose Sensing and Counterregulation in Defense of Hypoglycemia.

Stanley S, Moheet A, Seaquist ER.

Endocr Rev. 2019 Jun 1;40(3):768-788. doi: 10.1210/er.2018-00226.

PMID:
30689785
4.

Development of a model to predict 5-year risk of severe hypoglycemia in patients with type 2 diabetes.

Chow LS, Zmora R, Ma S, Seaquist ER, Schreiner PJ.

BMJ Open Diabetes Res Care. 2018 Aug 12;6(1):e000527. doi: 10.1136/bmjdrc-2018-000527. eCollection 2018.

5.

Beyond the brain: do peripheral mechanisms develop impaired awareness of hypoglycemia?

Seaquist ER.

J Clin Invest. 2018 Aug 31;128(9):3739-3741. doi: 10.1172/JCI122449. Epub 2018 Aug 6.

6.

Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real-world setting.

Seaquist ER, Dulude H, Zhang XM, Rabasa-Lhoret R, Tsoukas GM, Conway JR, Weisnagel SJ, Gerety G, Woo VC, Zhang S, Carballo D, Pradhan S, Piché CA, Guzman CB.

Diabetes Obes Metab. 2018 May;20(5):1316-1320. doi: 10.1111/dom.13278. Epub 2018 Mar 22.

7.

Type 1 Diabetes and Impaired Awareness of Hypoglycemia Are Associated with Reduced Brain Gray Matter Volumes.

Bednarik P, Moheet AA, Grohn H, Kumar AF, Eberly LE, Seaquist ER, Mangia S.

Front Neurosci. 2017 Sep 25;11:529. doi: 10.3389/fnins.2017.00529. eCollection 2017.

8.

Hypothalamic Glucose Transport in Humans During Experimentally Induced Hypoglycemia-Associated Autonomic Failure.

Seaquist ER, Moheet A, Kumar A, Deelchand DK, Terpstra M, Kubisiak K, Eberly LE, Henry PG, Joers JM, Öz G.

J Clin Endocrinol Metab. 2017 Sep 1;102(9):3571-3580. doi: 10.1210/jc.2017-00477.

9.

Erratum. Response to Comment on Pathak et al. Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005-2011. Diabetes Care 2016;39:363-370. Diabetes Care 2017;40:e26.

Pathak RD, Schroeder EB, Seaquist ER, Zeng C, Lafata JE, Thomas A, Lawrence JM, Karter AJ, Steiner JF, Segal J, O'Connor PJ; SUPREME-DM Study Group.

Diabetes Care. 2017 Oct;40(10):1420. doi: 10.2337/dc17-er10. Epub 2017 Aug 25. No abstract available.

10.

Hypoglycemia in Diabetes: Does Insulin Type Matter?

Seaquist ER, Chow LS.

JAMA. 2017 Jul 4;318(1):31-32. doi: 10.1001/jama.2017.8075. No abstract available.

PMID:
28672298
11.

Response to Comment on Pathak et al. Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005-2011. Diabetes Care 2016;39:363-370.

Pathak RD, Schroeder EB, Seaquist ER, Zeng C, Lafata JE, Thomas A, Lawrence JM, Karter AJ, Steiner JF, Segal J, O'Connor PJ; SUPREME-DM Study Group.

Diabetes Care. 2017 Feb;40(2):e26. doi: 10.2337/dci16-0037. No abstract available. Erratum in: Diabetes Care. 2017 Oct;40(10 ):1420.

12.

Cerebral glycogen in humans following acute and recurrent hypoglycemia: Implications on a role in hypoglycemia unawareness.

Öz G, DiNuzzo M, Kumar A, Moheet A, Khowaja A, Kubisiak K, Eberly LE, Seaquist ER.

J Cereb Blood Flow Metab. 2017 Aug;37(8):2883-2893. doi: 10.1177/0271678X16678240. Epub 2016 Jan 1.

13.

Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005-2011.

Pathak RD, Schroeder EB, Seaquist ER, Zeng C, Lafata JE, Thomas A, Desai J, Waitzfelder B, Nichols GA, Lawrence JM, Karter AJ, Steiner JF, Segal J, O'Connor PJ; SUPREME-DM Study Group.

Diabetes Care. 2016 Mar;39(3):363-70. doi: 10.2337/dc15-0858. Epub 2015 Dec 17.

14.

Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation and P-Wave Indices in the ACCORD Blood Pressure Trial.

Chen LY, Bigger JT, Hickey KT, Chen H, Lopez-Jimenez C, Banerji MA, Evans G, Fleg JL, Papademetriou V, Thomas A, Woo V, Seaquist ER, Soliman EZ.

Am J Hypertens. 2016 Nov 1;29(11):1276-1282. doi: 10.1093/ajh/hpv172.

15.

Factors associated with failure to achieve a glycated haemoglobin target of <8.0% in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Drake TC, Hsu FC, Hire D, Chen SH, Cohen RM, McDuffie R, Nylen E, O'Connor P, Rehman S, Seaquist ER.

Diabetes Obes Metab. 2016 Jan;18(1):92-5. doi: 10.1111/dom.12569. Epub 2015 Oct 26.

16.

Naltrexone for treatment of impaired awareness of hypoglycemia in type 1 diabetes: A randomized clinical trial.

Moheet A, Mangia S, Kumar A, Tesfaye N, Eberly LE, Bai Y, Kubisiak K, Seaquist ER.

J Diabetes Complications. 2015 Nov-Dec;29(8):1277-82. doi: 10.1016/j.jdiacomp.2015.08.004. Epub 2015 Aug 12.

17.

Biomarkers associated with severe hypoglycaemia and death in ACCORD.

Chow LS, Chen H, Miller ME, Marcovina SM, Seaquist ER.

Diabet Med. 2016 Aug;33(8):1076-83. doi: 10.1111/dme.12883. Epub 2015 Sep 6.

18.

Revisiting Glycogen Content in the Human Brain.

Öz G, DiNuzzo M, Kumar A, Moheet A, Seaquist ER.

Neurochem Res. 2015 Dec;40(12):2473-81. doi: 10.1007/s11064-015-1664-4. Epub 2015 Jul 23.

19.

Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1.

Skinner NE, Wroblewski MS, Kirihara JA, Nelsestuen GL, Seaquist ER.

Diabetes Ther. 2015 Sep;6(3):395-401. doi: 10.1007/s13300-015-0123-1. Epub 2015 Jul 22.

20.

The Impact of Diabetes on Cerebral Structure and Function.

Seaquist ER.

Psychosom Med. 2015 Jul-Aug;77(6):616-21. doi: 10.1097/PSY.0000000000000207. Review.

21.

Impact of diabetes on cognitive function and brain structure.

Moheet A, Mangia S, Seaquist ER.

Ann N Y Acad Sci. 2015 Sep;1353:60-71. doi: 10.1111/nyas.12807. Epub 2015 Jul 1. Review.

22.

2014 presidential address: stop diabetes--it is up to us.

Seaquist ER.

Diabetes Care. 2015 May;38(5):737-42. doi: 10.2337/dc14-2973.

PMID:
25908153
23.

Feasibility and reproducibility of neurochemical profile quantification in the human hippocampus at 3 T.

Bednařík P, Moheet A, Deelchand DK, Emir UE, Eberly LE, Bareš M, Seaquist ER, Öz G.

NMR Biomed. 2015 Jun;28(6):685-93. doi: 10.1002/nbm.3309. Epub 2015 Apr 22.

24.

Biomarkers related to severe hypoglycaemia and lack of good glycaemic control in ACCORD.

Chow LS, Chen H, Miller ME, Marcovina SM, Seaquist ER.

Diabetologia. 2015 Jun;58(6):1160-6. doi: 10.1007/s00125-015-3512-0. Epub 2015 Feb 5.

25.

Statement of principle.

Cefalu WT, Nair KS, Seaquist ER, Zierath J, Boulton AJ, LeRoith D, Harrell RM, Grunberger G, Wartofsky L, Gore AC, Wierman ME, Hammes SR, Lange CA, Santen RJ.

Horm Cancer. 2015 Feb;6(1):1. doi: 10.1007/s12672-014-0206-x. No abstract available.

PMID:
25410830
26.

Statement of principle.

Cefalu WT, Nair KS, Seaquist ER, Zierath J, Boulton AJ, LeRoith D, Harrell RM, Grunberger G, Wartofsky L, Gore AC, Wierman ME, Hammes SR, Lange CA, Santen RJ.

Endocr Rev. 2014 Dec;35(6):850. doi: 10.1210/er.2014-1089. Epub 2014 Nov 3. No abstract available.

PMID:
25365740
27.

Statement of principle.

Seaquist ER, Boulton AJ, Harrell RM, Grunberger G, Santen RJ.

Mol Endocrinol. 2014 Dec;28(12):1918. doi: 10.1210/me.2014-1338. No abstract available.

28.

Statement of principle.

Cefalu WT, Nair KS, Seaquist ER, Zierath J, Boulton AJ, LeRoith D, Harrell RM, Grunberger G, Wartofsky L, Gore AC, Wierman ME, Hammes SR, Lange CA, Santen RJ.

J Clin Endocrinol Metab. 2014 Dec;99(12):4376. doi: 10.1210/jc.2014-3958. No abstract available.

PMID:
25365410
29.

Frederick C. Goetz, MD: a profile of the intersection among science, the fine arts, and education.

Hoogwerf BJ, Kendall DM, Seaquist ER.

Diabetes Care. 2014 Sep;37(9):2419-23. doi: 10.2337/dc14-0283. No abstract available.

PMID:
25147251
30.

Addressing the burden of diabetes.

Seaquist ER.

JAMA. 2014 Jun 11;311(22):2267-8. doi: 10.1001/jama.2014.6451. No abstract available.

PMID:
24915253
31.

Training status diverges muscle diacylglycerol accumulation during free fatty acid elevation.

Chow LS, Mashek DG, Austin E, Eberly LE, Persson XM, Mashek MT, Seaquist ER, Jensen MD.

Am J Physiol Endocrinol Metab. 2014 Jul 1;307(1):E124-31. doi: 10.1152/ajpendo.00166.2014. Epub 2014 May 20.

32.

Diabetes: Hypoglycaemia, emergency care and diabetes mellitus.

Moheet A, Seaquist ER.

Nat Rev Endocrinol. 2014 Jul;10(7):384-5. doi: 10.1038/nrendo.2014.67. Epub 2014 May 6. No abstract available.

PMID:
24798062
33.

In vivo Magnetic Resonance Spectroscopy of cerebral glycogen metabolism in animals and humans.

Khowaja A, Choi IY, Seaquist ER, Öz G.

Metab Brain Dis. 2015 Feb;30(1):255-61. doi: 10.1007/s11011-014-9530-7. Epub 2014 Mar 28. Review.

34.

Hypoglycemia-associated autonomic failure in healthy humans: comparison of two vs three periods of hypoglycemia on hypoglycemia-induced counterregulatory and symptom response 5 days later.

Moheet A, Kumar A, Eberly LE, Kim J, Roberts R, Seaquist ER.

J Clin Endocrinol Metab. 2014 Feb;99(2):664-70. doi: 10.1210/jc.2013-3493. Epub 2013 Jan 1.

35.

The effect of nonsurgical periodontal therapy on hemoglobin A1c levels in persons with type 2 diabetes and chronic periodontitis: a randomized clinical trial.

Engebretson SP, Hyman LG, Michalowicz BS, Schoenfeld ER, Gelato MC, Hou W, Seaquist ER, Reddy MS, Lewis CE, Oates TW, Tripathy D, Katancik JA, Orlander PR, Paquette DW, Hanson NQ, Tsai MY.

JAMA. 2013 Dec 18;310(23):2523-32. doi: 10.1001/jama.2013.282431.

36.

Hypoglycemia as a driver of cardiovascular risk in diabetes.

Moheet A, Seaquist ER.

Curr Atheroscler Rep. 2013 Sep;15(9):351. doi: 10.1007/s11883-013-0351-7. Review.

37.

Diabetes: Does lactate sustain brain metabolism during hypoglycaemia?

Seaquist ER, Öz G.

Nat Rev Endocrinol. 2013 Jul;9(7):386-7. doi: 10.1038/nrendo.2013.104. Epub 2013 May 28. No abstract available.

PMID:
23712248
38.

Effect of thiazolidinediones and insulin on cognitive outcomes in ACCORD-MIND.

Seaquist ER, Miller ME, Fonseca V, Ismail-Beigi F, Launer LJ, Punthakee Z, Sood A.

J Diabetes Complications. 2013 Sep-Oct;27(5):485-91. doi: 10.1016/j.jdiacomp.2013.03.005. Epub 2013 May 13.

39.

Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society.

Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, Heller SR, Rodriguez H, Rosenzweig J, Vigersky R.

Diabetes Care. 2013 May;36(5):1384-95. doi: 10.2337/dc12-2480. Epub 2013 Apr 15.

40.

Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society.

Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, Heller SR, Rodriguez H, Rosenzweig J, Vigersky R; American Diabetes Association; Endocrine Society.

J Clin Endocrinol Metab. 2013 May;98(5):1845-59. doi: 10.1210/jc.2012-4127. Epub 2013 Apr 15.

PMID:
23589524
41.

Diagnostic accuracy of an "amended" insulin-glucose ratio for the biochemical diagnosis of insulinomas.

Cryer PE, Axelrod L, Grossman AB, Heller SR, Seaquist ER, Service FJ; Endocrine Society Task Force on the Evaluation and Management of Adult Hypoglycemic Disorders.

Ann Intern Med. 2013 Mar 19;158(6):500-1. doi: 10.7326/0003-4819-158-6-201303190-00020. No abstract available.

PMID:
23552360
42.

Initial experience with seven tesla magnetic resonance spectroscopy of hypothalamic GABA during hyperinsulinemic euglycemia and hypoglycemia in healthy humans.

Moheet A, Emir UE, Terpstra M, Kumar A, Eberly LE, Seaquist ER, Öz G.

Magn Reson Med. 2014 Jan;71(1):12-8. doi: 10.1002/mrm.24663. Epub 2013 Feb 19.

43.

Neurochemical profile of patients with type 1 diabetes measured by ¹H-MRS at 4 T.

Mangia S, Kumar AF, Moheet AA, Roberts RJ, Eberly LE, Seaquist ER, Tkáč I.

J Cereb Blood Flow Metab. 2013 May;33(5):754-9. doi: 10.1038/jcbfm.2013.13. Epub 2013 Feb 13.

44.

Evaluation of insulin secretion and action in New World camelids.

Firshman AM, Cebra CK, Schanbacher BJ, Seaquist ER.

Am J Vet Res. 2013 Jan;74(1):96-101. doi: 10.2460/ajvr.74.1.96.

PMID:
23270352
45.

American Diabetes Association research symposium: diabetes and the brain.

Seaquist ER, Lattemann DF, Dixon RA.

Diabetes. 2012 Dec;61(12):3056-62. doi: 10.2337/db12-0489. No abstract available.

46.

Hypoglycemia-induced increases in thalamic cerebral blood flow are blunted in subjects with type 1 diabetes and hypoglycemia unawareness.

Mangia S, Tesfaye N, De Martino F, Kumar AF, Kollasch P, Moheet AA, Eberly LE, Seaquist ER.

J Cereb Blood Flow Metab. 2012 Nov;32(11):2084-90. doi: 10.1038/jcbfm.2012.117. Epub 2012 Aug 15.

47.

Sweet and low: measuring brain glucose during hypoglycemia.

Seaquist ER, Öz G.

Diabetes. 2012 Aug;61(8):1918-9. doi: 10.2337/db12-0571. No abstract available.

48.

Estimated plasma stearoyl co-A desaturase-1 activity and risk of incident diabetes: the Atherosclerosis Risk in Communities (ARIC) study.

Chow LS, Li S, Eberly LE, Seaquist ER, Eckfeldt JH, Hoogeveen RC, Couper DJ, Steffen LM, Pankow JS.

Metabolism. 2013 Jan;62(1):100-8. doi: 10.1016/j.metabol.2012.06.004. Epub 2012 Jul 21.

49.

Acute free fatty acid elevation eliminates endurance training effect on insulin sensitivity.

Chow LS, Seaquist ER, Eberly LE, Mashek MT, Schimke JM, Nair KS, Mashek DG.

J Clin Endocrinol Metab. 2012 Aug;97(8):2890-7. doi: 10.1210/jc.2012-1515. Epub 2012 May 25.

50.

Is silent myocardial infarction more common in women with type 2 diabetes than in men?

Stiles MC, Seaquist ER, Yale JF, Green JB, Katz LA, Kempainen S, Light LS, Pepper PV, Zhang ZM, Soliman EZ.

J Diabetes Complications. 2012 Mar-Apr;26(2):118-22. doi: 10.1016/j.jdiacomp.2012.02.002. Epub 2012 Mar 24.

Supplemental Content

Loading ...
Support Center